From Abu Dhabi to the World: Genomics, AI and the New Age of Biotech

Abu Dhabi is rapidly establishing itself as a global leader in biotech innovation, building robust infrastructure for genomics and artificial intelligence (AI). This panel explores how the emirate’s unique ecosystem—powered by strategic partnerships and world-class resources—is fuelling the next generation of biotech discovery and proactive healthcare solutions.

Join the panel "From Abu Dhabi to the World: Genomics, AI and the New Age of Biotech" on June 25, as leaders share insights into how Abu Dhabi is building the critical infrastructure and ecosystem that transforms genomic data and AI capabilities into scalable biotech innovations with global impact:

• David Bearss, PhD, Co-Founder, CEO and President, Halia Therapeutics
• Marwan Mohamed, Life Science Cluster Lead, Masdar City
• Tiago Magalhaes, Vice President, Bioinformatics, M42
• Katrina Barker, Strategy and Partnerships Lead, Curated Capital